AGENUS INC — Director's Dealing 2023

Oct 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MiNK Therapeutics, Inc. (INKT)
CIK: 0001840229
Period of Report: 2023-10-12

Reporting Person: AGENUS INC (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-12	Common Stock	P	3173	$1.0994	Acquired	21753061	Direct
2023-10-13	Common Stock	P	19373	$1.10	Acquired	21772434	Direct
2023-10-16	Common Stock	P	429	$1.0992	Acquired	21772863	Direct

Footnotes

F1: Open market purchases reported on this line occurred at a weighted average price of $1.0994 (range of $1.08 to $1.10).

F2: Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.

F3: Open market purchases reported on this line occurred at a price of $1.10.

F4: Open market purchases reported on this line occurred at a weighted average price of $1.0992 (range of $1.09 to $1.10).